Published in EMBO J on November 15, 2000
Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J (2002) 6.37
PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev (2001) 5.79
Oncogenic ras and p53 cooperate to induce cellular senescence. Mol Cell Biol (2002) 2.61
Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol (2007) 2.56
Transcription factor Sp3 is silenced through SUMO modification by PIAS1. EMBO J (2002) 2.41
SUMO-specific protease 2 is essential for modulating p53-Mdm2 in development of trophoblast stem cell niches and lineages. PLoS Biol (2008) 2.35
Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. Mol Cell Biol (2003) 2.17
Higher order arrangement of the eukaryotic nuclear bodies. Proc Natl Acad Sci U S A (2002) 1.99
Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene (2007) 1.92
Activation and activities of the p53 tumour suppressor protein. Br J Cancer (2001) 1.90
Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence. Mol Cell Biol (2002) 1.83
Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein. Cancer Cell (2010) 1.72
Definition of pRB- and p53-dependent and -independent steps in HIRA/ASF1a-mediated formation of senescence-associated heterochromatin foci. Mol Cell Biol (2007) 1.62
Ubiquitin-mediated fluorescence complementation reveals that Jun ubiquitinated by Itch/AIP4 is localized to lysosomes. Proc Natl Acad Sci U S A (2004) 1.58
Deconstructing PML-induced premature senescence. EMBO J (2002) 1.56
Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodies. J Virol (2011) 1.49
"Where, O death, is thy sting?" A brief review of apoptosis biology. Mol Neurobiol (2010) 1.47
SIRT1 and p53, effect on cancer, senescence and beyond. Biochim Biophys Acta (2010) 1.46
A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics. Int J Biol Sci (2010) 1.38
Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense. J Virol (2006) 1.30
PML colocalizes with and stabilizes the DNA damage response protein TopBP1. Mol Cell Biol (2003) 1.29
SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein. Proc Natl Acad Sci U S A (2001) 1.26
Regulation of E2Fs and senescence by PML nuclear bodies. Genes Dev (2011) 1.25
Ubiquitin-dependent degradation of p73 is inhibited by PML. J Exp Med (2004) 1.24
MOZ increases p53 acetylation and premature senescence through its complex formation with PML. Proc Natl Acad Sci U S A (2013) 1.19
SUMOylation regulates nuclear localization of Krüppel-like factor 5. J Biol Chem (2008) 1.18
PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation. Mol Cell Biol (2008) 1.17
Impairment of p53 acetylation, stability and function by an oncogenic transcription factor. EMBO J (2004) 1.16
SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4. Mol Cell Biol (2005) 1.16
Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription. Mol Cell Biol (2008) 1.15
Differential Roles of PML Isoforms. Front Oncol (2013) 1.13
PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins. J Cell Biol (2006) 1.12
SIRT1 stabilizes PML promoting its sumoylation. Cell Death Differ (2010) 1.10
Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways. Mol Cell Biol (2005) 1.08
Ubiquitin and ubiquitin-like modifications of the p53 family. Neoplasia (2006) 1.05
Tied up in loops: positive and negative autoregulation of p53. Cold Spring Harb Perspect Biol (2009) 1.05
SUMO-specific protease 2 in Mdm2-mediated regulation of p53. Cell Death Differ (2010) 1.04
Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection. J Virol (2012) 1.03
Adenovirus E1B 55-kilodalton protein is a p53-SUMO1 E3 ligase that represses p53 and stimulates its nuclear export through interactions with promyelocytic leukemia nuclear bodies. J Virol (2010) 1.01
Nuclear and cytoplasmic shuttling of TRADD induces apoptosis via different mechanisms. J Cell Biol (2002) 1.00
Dynamic regulation of p53 subnuclear localization and senescence by MORC3. Mol Biol Cell (2007) 0.99
Live cell dynamics of promyelocytic leukemia nuclear bodies upon entry into and exit from mitosis. Mol Biol Cell (2008) 0.98
Modification of Drosophila p53 by SUMO modulates its transactivation and pro-apoptotic functions. J Biol Chem (2008) 0.97
Herpesvirus protein ICP27 switches PML isoform by altering mRNA splicing. Nucleic Acids Res (2009) 0.97
p53 Acetylation: Regulation and Consequences. Cancers (Basel) (2014) 0.97
MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs. Cell Death Differ (2011) 0.96
Adenovirus type 5 early region 1B 55K oncoprotein-dependent degradation of cellular factor Daxx is required for efficient transformation of primary rodent cells. J Virol (2011) 0.95
Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML. Nucleic Acids Res (2003) 0.95
Resistance to rabies virus infection conferred by the PMLIV isoform. J Virol (2010) 0.94
A small ubiquitin-related modifier-interacting motif functions as the transcriptional activation domain of Krüppel-like factor 4. J Biol Chem (2010) 0.92
FAT10 modifies p53 and upregulates its transcriptional activity. Arch Biochem Biophys (2011) 0.92
Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma. J Virol (2011) 0.92
The role of post-translational modifications in fine-tuning BLM helicase function during DNA repair. DNA Repair (Amst) (2014) 0.91
The PML nuclear bodies-associated protein TTRAP regulates ribosome biogenesis in nucleolar cavities upon proteasome inhibition. Cell Death Differ (2011) 0.91
Beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells. Am J Pathol (2004) 0.91
The adenoviral E1B 55-kilodalton protein controls expression of immune response genes but not p53-dependent transcription. J Virol (2009) 0.91
The tumor suppressor PML specifically accumulates at RPA/Rad51-containing DNA damage repair foci but is nonessential for DNA damage-induced fibroblast senescence. Mol Cell Biol (2014) 0.90
Post-translational modifications of PML: consequences and implications. Front Oncol (2013) 0.88
Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner. Cell Cycle (2013) 0.88
Direct interaction between scaffolding proteins RACK1 and 14-3-3ζ regulates brain-derived neurotrophic factor (BDNF) transcription. J Biol Chem (2011) 0.88
The adenoviral oncogene E1A-13S interacts with a specific isoform of the tumor suppressor PML to enhance viral transcription. J Virol (2012) 0.87
Influence of ND10 components on epigenetic determinants of early KSHV latency establishment. PLoS Pathog (2014) 0.86
JAZ mediates G1 cell-cycle arrest and apoptosis by positively regulating p53 transcriptional activity. Blood (2006) 0.86
Promyelocytic leukemia nuclear bodies support a late step in DNA double-strand break repair by homologous recombination. J Cell Biochem (2012) 0.86
Reconstitution of Mdm2-dependent post-translational modifications of p53 in yeast. PLoS One (2008) 0.85
Move or die: the fate of the Tax oncoprotein of HTLV-1. Viruses (2011) 0.85
Identifying gene locus associations with promyelocytic leukemia nuclear bodies using immuno-TRAP. J Cell Biol (2013) 0.84
PML isoforms in response to arsenic: high-resolution analysis of PML body structure and degradation. J Cell Sci (2013) 0.83
Killing of p53-deficient hepatoma cells by parvovirus H-1 and chemotherapeutics requires promyelocytic leukemia protein. World J Gastroenterol (2008) 0.82
Inhibition of Sp1 functions by its sequestration into PML nuclear bodies. PLoS One (2014) 0.82
Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms. PLoS One (2012) 0.82
Is PML a Tumor Suppressor? Front Oncol (2013) 0.82
Down-regulation of LATS kinases alters p53 to promote cell migration. Genes Dev (2015) 0.81
p53 and p21(Waf1) are recruited to distinct PML-containing nuclear foci in irradiated and Nutlin-3a-treated U2OS cells. J Cell Biochem (2010) 0.81
PML3 Orchestrates the Nuclear Dynamics and Function of TIP60. J Biol Chem (2009) 0.81
PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation. Nucleus (2014) 0.79
Critical role of presenilin-dependent γ-secretase activity in DNA damage-induced promyelocytic leukemia protein expression and apoptosis. Cell Death Differ (2013) 0.79
Daxx-beta and Daxx-gamma, two novel splice variants of the transcriptional co-repressor Daxx. J Biol Chem (2011) 0.79
PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53. Oncogene (2015) 0.79
Biochemical characterization of the small ubiquitin-like modifiers of Chlamydomonas reinhardtii. Planta (2010) 0.78
Immunohistochemical expression of promyelocytic leukemia body in soft tissue sarcomas. J Exp Clin Cancer Res (2008) 0.77
Nuclear microenvironment in cancer diagnosis and treatment. J Cell Biochem (2008) 0.77
Differential sub-nuclear distribution of hypoxia-inducible factors (HIF)-1 and -2 alpha impacts on their stability and mobility. Open Biol (2016) 0.77
PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers. Oncogene (2009) 0.76
A Crowdsourced nucleus: understanding nuclear organization in terms of dynamically networked protein function. Biochim Biophys Acta (2014) 0.76
Impact of the adenoviral E4 Orf3 protein on the activity and posttranslational modification of p53. J Virol (2015) 0.76
A novel single cell method to identify the genetic composition at a single nuclear body. Sci Rep (2016) 0.76
RNF38 encodes a nuclear ubiquitin protein ligase that modifies p53. Biochem Biophys Res Commun (2013) 0.75
PML nuclear bodies contribute to the basal expression of the mTOR inhibitor DDIT4. Sci Rep (2017) 0.75
A platform for interrogating cancer-associated p53 alleles. Oncogene (2016) 0.75
WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72
p53, the cellular gatekeeper for growth and division. Cell (1997) 31.04
p53: puzzle and paradigm. Genes Dev (1996) 13.16
A model for p53-induced apoptosis. Nature (1997) 11.38
Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell (1991) 9.40
A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell (1997) 9.01
The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell (1991) 8.98
The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature (1999) 7.85
The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev (1998) 7.46
A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell (1994) 6.52
PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol (1999) 5.83
Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell (1994) 5.37
Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J (1998) 5.15
Recruitment of p300/CBP in p53-dependent signal pathways. Cell (1997) 5.10
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature (2000) 4.90
The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J (1994) 4.29
SUMO-1 modification activates the transcriptional response of p53. EMBO J (1999) 4.19
Role of SUMO-1-modified PML in nuclear body formation. Blood (2000) 4.05
Role of PML in cell growth and the retinoic acid pathway. Science (1998) 3.82
The transcriptional role of PML and the nuclear body. Nat Cell Biol (2000) 3.80
PML is essential for multiple apoptotic pathways. Nat Genet (1998) 3.75
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood (1997) 3.56
PML is induced by oncogenic ras and promotes premature senescence. Genes Dev (2000) 3.35
Nuclear domain 10, the site of DNA virus transcription and replication. Bioessays (1998) 3.13
Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J (1999) 3.08
Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol (1997) 2.98
Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol Cell (1999) 2.93
The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene (1995) 2.80
c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem (2000) 2.71
PML induces a novel caspase-independent death process. Nat Genet (1998) 2.66
Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc Natl Acad Sci U S A (1998) 2.59
Identification of three major sentrinization sites in PML. J Biol Chem (1998) 2.54
The cellular response to p53: the decision between life and death. Oncogene (1999) 2.31
Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc Natl Acad Sci U S A (1998) 2.21
The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J Biol Chem (1999) 2.21
Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO J (1999) 1.99
Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b. J Virol (2000) 1.91
The growth arrest-specific gene, gas1, is involved in growth suppression. Cell (1992) 1.89
An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. Exp Cell Res (1999) 1.74
The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol Cell Biol (1998) 1.69
Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. Am J Hum Genet (1998) 1.64
Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage. Mol Cell Biol (1996) 1.61
Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene (1992) 1.59
The PML nuclear bodies: actors or extras? Curr Opin Genet Dev (1999) 1.40
Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide. Proc Natl Acad Sci U S A (1996) 1.31
Nijmegen breakage syndrome disease protein and MRE11 at PML nuclear bodies and meiotic telomeres. Cancer Res (2000) 1.20
Human p53 binds DNA as a protein homodimer but monomeric variants retain full transcription transactivation activity. Oncogene (1993) 1.17
Molecular genetics of acute promyelocytic leukemia. Trends Genet (1999) 1.16
Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22. Mol Biol Cell (1999) 1.05
COOH-terminal domain of p53 modulates p53-mediated transcriptional transactivation, cell growth, and apoptosis. Cancer Res (1999) 1.03
p53 is involved in the p120E4F-mediated growth arrest. Oncogene (2000) 1.01
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature (2002) 28.79
Pten is essential for embryonic development and tumour suppression. Nat Genet (1998) 13.41
Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol (1969) 10.85
Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (1995) 9.79
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet (1998) 8.20
The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature (1999) 7.85
Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature (1998) 7.76
A new sensitive method for qualitative and quantitative assay of neomycin phosphotransferase in crude cell extracts. Gene (1984) 7.36
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med (1998) 6.83
The multiple roles of PTEN in tumor suppression. Cell (2000) 6.71
A one-step purification of membrane proteins using a high efficiency immunomatrix. J Biol Chem (1982) 6.70
Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet (2001) 5.92
Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell (1997) 5.73
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet (1997) 5.55
Signals regulating hepatitis B surface antigen transcription. Nature (1983) 5.02
An atomic-resolution nanomechanical mass sensor. Nat Nanotechnol (2008) 4.92
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature (2000) 4.90
The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol Chemother (1968) 4.75
Comparative sequence analysis of duck and human hepatitis B virus genomes. J Med Virol (1985) 4.68
Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc Natl Acad Sci U S A (1981) 4.50
Cloning of the human cDNA for the U1 RNA-associated 70K protein. EMBO J (1986) 4.43
Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity. Mol Cell Biol (1999) 4.42
Replication strategy of human hepatitis B virus. J Virol (1987) 4.42
Transcripts and the putative RNA pregenome of duck hepatitis B virus: implications for reverse transcription. Cell (1985) 4.41
High-efficiency full-length cDNA cloning by biotinylated CAP trapper. Genomics (1996) 4.41
The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene (2008) 4.39
Convenient single-step, one tube purification of PCR products for direct sequencing. Nucleic Acids Res (1994) 4.30
Impaired Fas response and autoimmunity in Pten+/- mice. Science (1999) 4.25
Role of SUMO-1-modified PML in nuclear body formation. Blood (2000) 4.05
Primary structure of human transferrin receptor deduced from the mRNA sequence. Nature (1984) 4.04
Role of PML in cell growth and the retinoic acid pathway. Science (1998) 3.82
The transcriptional role of PML and the nuclear body. Nat Cell Biol (2000) 3.80
PML is essential for multiple apoptotic pathways. Nat Genet (1998) 3.75
Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J Exp Med (2001) 3.62
The CTAB-DNA precipitation method: a common mini-scale preparation of template DNA from phagemids, phages or plasmids suitable for sequencing. Biotechniques (1989) 3.54
A one-tube plasmid DNA mini-preparation suitable for sequencing. Nucleic Acids Res (1988) 3.51
Hepatitis B virus transcription in the infected liver. EMBO J (1984) 3.44
A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol (1995) 3.35
Structure of a Bag/Hsc70 complex: convergent functional evolution of Hsp70 nucleotide exchange factors. Science (2001) 3.27
Isolation and characterization of a hepatitis B virus endemic in herons. J Virol (1988) 3.23
Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci (2000) 3.14
Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J (1999) 3.08
Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem (1996) 3.00
Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol (1997) 2.98
Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. Nat Genet (1998) 2.97
The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol (1993) 2.95
Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol Psychiatry (2001) 2.84
The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene (1995) 2.80
Cloned HBV DNA causes hepatitis in chimpanzees. Nature (1982) 2.80
MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology (2000) 2.77
Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell (1995) 2.75
Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol (1990) 2.73
Monoclonal antibodies OKT 11 and OKT 11A have pan-T reactivity and block sheep erythrocyte "receptors". Eur J Immunol (1982) 2.72
Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology (2001) 2.71
The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem (1998) 2.71
Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology (2003) 2.70
Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J Natl Cancer Inst (1998) 2.64
Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem (1997) 2.63
BCL-6 regulates chemokine gene transcription in macrophages. Nat Immunol (2000) 2.58
Genetic analysis using genomic representations. Proc Natl Acad Sci U S A (1998) 2.52
Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. Proc Natl Acad Sci U S A (1997) 2.47
A new and fast method for preparing high quality lambda DNA suitable for sequencing. Nucleic Acids Res (1988) 2.46
Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa. J Clin Microbiol (1995) 2.43
The function of PML in p53-dependent apoptosis. Nat Cell Biol (2000) 2.24
IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J Immunol (1992) 2.24
A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis. Neurology (2006) 2.24
The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J Biol Chem (1999) 2.21
Infectious hepatitis B virus from cloned DNA of known nucleotide sequence. Proc Natl Acad Sci U S A (1985) 2.20
The transmembrane segment of the human transferrin receptor functions as a signal peptide. EMBO J (1986) 2.18
A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques (1991) 2.15
Plzf regulates limb and axial skeletal patterning. Nat Genet (2000) 2.14
Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc Natl Acad Sci U S A (1994) 2.14
Denitrification, dissimilatory reduction of nitrate to ammonium, and nitrification in a bioturbated estuarine sediment as measured with N and microsensor techniques. Appl Environ Microbiol (1992) 2.12
High efficiency selection of full-length cDNA by improved biotinylated cap trapper. DNA Res (1997) 2.11
HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J (1996) 2.09
Acute promyelocytic leukemia: from genetics to treatment. Blood (1994) 2.09
Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. J Biol Chem (1994) 2.08
Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci U S A (1991) 2.05
Cell cycle regulation of PML modification and ND10 composition. J Cell Sci (1999) 2.04
Modification of morphine withdrawal by drugs interacting with humoral mechanisms: some contradictions and their interpretation. Nature (1972) 2.04
[A patient with muscle pain after a journey to the tropics. Myocardial involvement in proximal myotonic myopathy]. Dtsch Med Wochenschr (1998) 2.03
Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue. AIDS (1999) 2.00
Putative reverse transcriptase intermediates of human hepatitis B virus in primary liver carcinomas. Science (1986) 2.00
Totally extraperitoneal endoscopic inguinal hernia repair (TEP). Surg Endosc (2002) 2.00
Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. J Clin Invest (2001) 2.00
A novel U2 and U11/U12 snRNP protein that associates with the pre-mRNA branch site. EMBO J (2001) 1.97
Monoclonal antibodies against chromosomal proteins of Drosophila melanogaster: establishment of antibody producing cell lines and partial characterization of corresponding antigens. Chromosoma (1980) 1.97
A role for PML and the nuclear body in genomic stability. Oncogene (1999) 1.97
The theory of APL revisited. Curr Top Microbiol Immunol (2007) 1.96
Identification of both shared and distinct proteins in the major and minor spliceosomes. Science (1999) 1.96
Expression of the hepatitis B virus core gene in vitro and in vivo. J Virol (1987) 1.96
The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J Virol (1992) 1.95
A European survey of diagnostic methods and testing protocols for Clostridium difficile. Clin Microbiol Infect (2003) 1.94
Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switching. Mol Cell Biol (1999) 1.91